Invention Grant
US09255272B2 Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
有权
使用白三烯B4受体BLT2抑制剂治疗哮喘
- Patent Title: Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
- Patent Title (中): 使用白三烯B4受体BLT2抑制剂治疗哮喘
-
Application No.: US14298423Application Date: 2014-06-06
-
Publication No.: US09255272B2Publication Date: 2016-02-09
- Inventor: Jae-Hong Kim
- Applicant: Korea University Research & Business Foundation
- Applicant Address: KR Seoul
- Assignee: Korea University Research and Business Foundation
- Current Assignee: Korea University Research and Business Foundation
- Current Assignee Address: KR Seoul
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Kongsik Kim; Elaine V. Morlock
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/713 ; C12N15/113 ; C07K16/28 ; G01N33/88 ; A61K39/00

Abstract:
The present invention relates to the use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma. More particularly, the present invention relates to a pharmaceutical composition for treating asthma comprising BLT2 inhibitors and a method for treating asthma using BLT2 inhibitors.
Public/Granted literature
- US20140287503A1 USE OF INHIBITORS OF LEUKOTRIENE B4 RECEPTOR BLT2 FOR TREATING ASTHMA Public/Granted day:2014-09-25
Information query